Market Place
Sourcing Support
RedHill Biopharma Announces $36 M Strategic Investment by Cosmo Pharmaceuticals
19 Oct 2019 //
BIOSPACE
2018 Drug Approvals: A Closer Look
05 Feb 2019 //
SCIENCE MAG BLOG
Cosmo to give Bausch Health a run for its money with FDA nod for Xifaxan rival
21 Nov 2018 //
FIERCE PHARMA
FDA approves new drug to treat travelers’ diarrhea
17 Nov 2018 //
FDA
FDA accepts NDA for Aemcolo (Rifamycin SV MMX®) and sets PDUFA Date
21 May 2018 //
PR NEWSWIRE
Valeant: A Rifamycin Threat Could Be Devastating
23 Mar 2018 //
SEEKINGALPHA
Valeant partner Cosmo turns wannabe IBS-D rival, and it could do some sales damage: analyst
29 Jan 2018 //
FIERCE PHARMA
Anvisa Suspends Two EMS Drugs
04 Feb 2015 //
ANVISA
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.